D-PLLA (poly-D-lactic acid) is a biodegradable, biocompatible synthetic polymer and stereochemical isomer of polylactic acid. In aesthetic and regenerative medicine it acts as a biostimulant used to improve tissue structure and skin quality.

Compared to the L isomer, D-PLLA has different tissue-response dynamics, which is clinically relevant for planning therapy and expected time to effect.

Mechanism of action

After injection into tissues:

• D-PLLA microspheres initiate a controlled biological response,
• fibroblasts are activated and collagen synthesis is stimulated,
• gradual remodeling of the extracellular matrix occurs,
• the product biodegrades in a predictable and reversible manner.

The therapeutic effect is not a direct filler effect, but the result of regenerative processes in the dermis that improve structure and density.

Clinical dynamics

D-PLLA is characterized by:

• a faster onset of clinical effect compared to the L isomer,
• a shorter duration of therapeutic effects.

Therefore D-PLLA is chosen when earlier visible improvement is important, while preserving collagen stimulation and a natural effect.

D-PLLA products

In clinical practice, D-PLLA is used alone or as part of combined products.

Hybrid products combine D-PLLA microspheres with hyaluronic acid, intended for therapies that improve skin structure and quality.

Benefits:

• relatively fast clinical improvement,
• long-term skin regeneration,
• natural proportions without excessive volumization.

Hybrid D-PLLA products bridge classic biostimulators and regenerative therapies with a more dynamic tissue response.

Clinical indications

Treatments with D-PLLA (including Juvelook® and Lenisna®) may be used in patients:

• with loss of skin quality and density,
• with signs of structural aging,
• after weight loss,
• expecting earlier visible improvement,
• preferring a natural regenerative effect without pronounced volumization.

Most common areas:

• face,
• periocular area,
• selected body areas requiring improved skin quality.

Therapy profile and safety

• individualized treatment planning,
• procedures performed exclusively by a physician,
• D-PLLA can be part of combined therapies,
• short recovery, with possible transient local reactions.

Selection of product and injection technique requires clinical experience and precise medical qualification.